Skip to main content
Top
Published in: Critical Care 1/2020

01-12-2020 | COVID-19 | Research Letter

The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study

Authors: Matilde Tejlbo Frost, Espen Jimenez-Solem, Mikkel Zöllner Ankarfeldt, Martin Erik Nyeland, Anne Helms Andreasen, Tonny Studsgaard Petersen

Published in: Critical Care | Issue 1/2020

Login to get access

Excerpt

The recently published ‘Adaptive COVID-19 Treatment Trial’ (ACTT-1) showed that remdesivir is a promising treatment option against coronavirus disease 2019 (COVID-19) [1]. Consequently, remdesivir is now being evaluated for implementation in clinical practice worldwide. …
Literature
3.
Metadata
Title
The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study
Authors
Matilde Tejlbo Frost
Espen Jimenez-Solem
Mikkel Zöllner Ankarfeldt
Martin Erik Nyeland
Anne Helms Andreasen
Tonny Studsgaard Petersen
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2020
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-020-03406-3

Other articles of this Issue 1/2020

Critical Care 1/2020 Go to the issue